Partners in Innovation: Advancing Georgetown’s breakthroughs for a brighter tomorrow
At Georgetown’s Office of Technology Commercialization, we are driven by a passionate commitment to transforming innovations into impactful solutions.
We are dedicated to propelling GU’s pioneering breakthroughs forward through strategic partnerships and creating new ventures. We are dedicated to bridging the gap between research excellence and real-world application, fostering an environment where entrepreneurship thrives, and ensuring our entire community benefits.
As your partners in innovation and research translation, we engage continuously with knowledgeable and accessible staff, ensuring your ideas make a meaningful impact on society. Welcome to a world of possibilities at the intersection of academia and entrepreneurship!
Featured News, Research Showcase
Georgetown’s research and entrepreneurship ecosystems converge to honor innovators
A cornerstone of the annual Georgetown University Research & Innovation Showcase, the 2026 Innovation & Entrepreneurship Awards combined OTC’s Crystal Awards and Georgetown Entrepreneurship’s Entrepreneurial Excellence Awards ceremonies.
April 28, 2026
Featured News, Research Showcase
Partnerships power possibilities: Georgetown showcases the future of research and innovation
More than 400 investors, industry executives, scientists, policy leaders, and entrepreneurs came together for the 2026 Georgetown University Research & Innovation Showcase, exploring how university research drives the next generation of global solutions
April 28, 2026
Featured News
New 3-D-Printed Bone Grafts Could Make Implants Safer and More Effective
Bone grafts are common procedures but can often lead to infection, pain and rejection by the human body. Stella Alimperti is developing 3D-printed bone grafts based on natural materials that could make procedures safer and more effective.
March 31, 2026
Georgetown researchers have developed a cutting-edge method involving tumor biopsies and zebrafish xenografts to assess the potential response to CAR-T cell therapy before treatment initiation.
Georgetown University has pioneered a remarkable synthetic lung surfactant known as “Fibractant.” Composed of silk fibroin and DPPC lipids, this innovation holds high potential in the realm of respiratory care, offering a sustainable alternative to conventional methods.
Learn MoreGeorgetown University researchers have developed a groundbreaking technology that addresses the critical need for mitigating adverse secondary effects from minimally invasive medical procedures, monitoring, and drug delivery devices.
Learn MoreThis event promises to be a remarkable celebration of the astounding achievements of our dedicated faculty and researchers as they continue to make profound contributions to society through their groundbreaking inventions.
MORE DETAILS FORTHCOMING
